11-68900582-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181514.2(MRPL21):āc.112A>Gā(p.Arg38Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181514.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL21 | NM_181514.2 | c.112A>G | p.Arg38Gly | missense_variant | 2/7 | ENST00000362034.7 | NP_852615.1 | |
MRPL21 | XM_005273823.5 | c.112A>G | p.Arg38Gly | missense_variant | 2/6 | XP_005273880.1 | ||
MRPL21 | NM_181515.2 | c.-157A>G | 5_prime_UTR_variant | 2/7 | NP_852616.1 | |||
MRPL21 | XR_247190.5 | n.134A>G | non_coding_transcript_exon_variant | 2/6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251472Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135902
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461658Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 727150
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2023 | The c.112A>G (p.R38G) alteration is located in exon 2 (coding exon 2) of the MRPL21 gene. This alteration results from a A to G substitution at nucleotide position 112, causing the arginine (R) at amino acid position 38 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at